Status: Recruiting
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
Participants needed: 60
Trial details
Phase: Phase 4Age: 50-80Biological sex: AllType: InterventionalSponsor: Potsawat SurabotsoponUpdated: Sep 8, 2025Locations: 1
Eligibility criteria
Age range: 50-80 years old. [+1]
Previously undergone spine surgery. [+3]